Studies have also shown that higher proportions of virus-specific CD4+ T cells and T follicular helper (Tfh) cells are associated with milder COVID-19 symptoms [33], as well as a slower decline in humoral immunity [34]. The gene discussed is CD4; the disease is COVID-19.